Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers.
about
Recent advances in multidisciplinary management of hepatocellular carcinomaRole of positron emission tomography/computed tomography in living donor liver transplantation for hepatocellular carcinomaGenetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.Micro RNA expression profiles as adjunctive data to assess the risk of hepatocellular carcinoma recurrence after liver transplantation.Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation.Elevated CA19-9 Is Associated With Increased Mortality In A Prospective Cohort Of Hepatocellular Carcinoma Patients.Molecular pathology of hepatic neoplasms: classification and clinical significance.Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinomaMolecular Determinants of Prognosis in Hepatocellular Carcinoma.Management of hepatocellular carcinoma: Enlightening the gray zones.Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery.Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation.Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis.Current controversies surrounding liver transplantation for hepatocellular carcinoma.Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma.Hepatocellular carcinoma review: current treatment, and evidence-based medicine.Cellular prognostic markers in hepatocellular carcinoma.Curative therapies for hepatocellular carcinoma: an update and perspectives.Insertion/deletion polymorphisms are convenient and reliable markers to assess chromosomal instability in human tumors.Novel metronomic chemotherapy and cancer vaccine combinatorial strategy for hepatocellular carcinoma in a mouse model.Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase.Molecular markers and hepatocellular carcinoma: lending a helping hand in liver transplantation?Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directionsProposal of new expanded selection criteria using total tumor size and (18)F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer C
P2860
Q26863748-720B621A-CE8A-41A8-981B-786B979CED9EQ28067010-BB719CF5-471A-4B1F-A5BD-50AB8CE0292EQ31037974-CD306B60-DA75-4587-981F-E98559FDFB43Q34050935-073C189E-69EB-4DF2-B16D-F5CFB2DDB946Q34165090-D5C67DEF-64F5-4B0E-B80A-B42329B22760Q34667817-B600D0CB-2502-4676-B002-44ADD7284039Q34954493-7229E8F4-7996-4994-A968-136EEEF9ED46Q35187751-358C259D-5D9D-4DD2-8AFF-A3D8300A1D1AQ35905975-BD45831E-85B4-4D3E-A662-D7118FA9C785Q36955647-CADAF69B-BDB9-45A8-9E0F-AD947FA08536Q36962089-AE4D6CCA-3325-4276-8F80-FC8D950E8ECDQ37076019-54FD0BAA-8CF1-4B4D-BAA8-BB8D14798D43Q37565675-57CA9075-1990-4860-89A1-99DD790B1576Q37636484-779515E4-4D7F-4BCF-9476-2186F2D5AE99Q37769279-78A3E737-6DBD-4341-A309-9319D8B11294Q37995306-97BE914B-A730-41A5-B39C-79F945DD8E0CQ38207012-47667FA9-C801-4BC7-852B-C65A9B144E81Q38515812-ACEB2A69-0056-4ACD-9B68-D27BA0F6CAB5Q38640531-A0F080E1-189A-443E-A9EA-8AB390DDE8CAQ39609298-AA227F6F-63AE-4223-BFEF-585488513DDDQ41257562-5A8E602A-150F-4FC9-8B0E-6354DF168550Q43787353-E2A759C8-80DD-447F-9BAB-7ABC6A81AEA4Q45952585-D8EFAFF8-A5D0-400A-8E91-2F0DDCDBF248Q47682080-E1A6F45A-1B60-4CFA-9976-778B71C05684Q57167305-CC4C13FF-2705-4CCF-863B-1387D670A038Q57219629-1DBD5426-6B50-4B7F-8627-1EEB6D93F603
P2860
Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Liver transplantation for hepa ...... ns based on molecular markers.
@en
Liver transplantation for hepa ...... ns based on molecular markers.
@nl
type
label
Liver transplantation for hepa ...... ns based on molecular markers.
@en
Liver transplantation for hepa ...... ns based on molecular markers.
@nl
prefLabel
Liver transplantation for hepa ...... ns based on molecular markers.
@en
Liver transplantation for hepa ...... ns based on molecular markers.
@nl
P2093
P2860
P1476
Liver transplantation for hepa ...... ns based on molecular markers.
@en
P2093
Igor Dvorchik
J Wallis Marsh
John A Martignetti
M Isabel Fiel
Myron Schwartz
Sasan Roayaie
Sidney Finkelstein
P2860
P304
P356
10.1016/J.JHEP.2008.03.032
P577
2008-05-20T00:00:00Z